| Group (count of samples) | MSI (frequency) | MSI-H (frequency) | MSI-L (frequency) | hMLH1 methylation (frequency) |
|---|---|---|---|---|
| Gastric cancer (41) | 22 (53.7%) | 8 (19.5%) | 14(34.1%) | 17(41.5%) |
| Intestinal type (15) | 9 (60.0%) | 6 (40.0%) | 3 (20.0%) | 8 (53.3%) |
| Diffuse type (26) | 13 (50.0%) | 2 (7.7%) | 11 (42.3%) | 9(41.5%) |
| Precancerous lesions (46) | 12(26.1%) | 6(13.0%) | 6 (13.0%) | 9 (19.6%) |
| Normal control (14) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Total (101) | 34 (33.7%) | 14(13.9%) | 20(19.8%) | 26 (25.7%) |